Chris Hemsworth is a famous Australian actor who got global recognition by portraying the role of Thor in the Marvel Cinematic Universe. He has continued to entice fans’ attention with his on-screen presence and established himself among the world’s highest-paid actors.
While he is part of a great franchise, Hemsworth turned down the offer to return to the popular Star Trek franchise as he was not pleased with the script.
Chris Hemsworth Won’t Return to Star Trek Franchise!
The 39-year-old actor, Chris Hemsworth played the role of George Kirk in 2009’s Star Trek alongside Chris Pine. The J.J. Abrams-helmed film was a critical and commercial success that grossed over $385.7 million.
While the former’s character was not seen in the sequels of the film, reports opened up about his return to Star Trek 4 which has been in development since 2016.
However, the former dropped out of the casting lineup and shared the reason behind leaving the project in a 2019 interview with Variety.
Chris Hemsworth shared that he did not feel hooked up to the script. “I didn’t feel like we landed on a reason to revisit that yet.”
He continued, “I didn’t want to be underwhelmed by what I was going to bring to the table.”
Though the actor has gotten quite selective in his projects since getting enough exposure to deal with those situations, his co-star, Chris Pine also felt displeased by the film’s development as he once mentioned how actors are often kept in dark.
Chris Hemsworth is Slowing Down in Taking on Future Projects
While the actor has turned down reprising his role in Star Trek 4, he has opened up about taking some time off from acting due to his medical condition. While filming for his docuseries, Limitless, he learned that he has a significantly high risk of developing Alzheimer’s disease.
As per reports, he has two copies of the gene ApoE4 which is quite rare as about 2 or 3 percent of the population carry two copies of the gene. He learned that he got two copies of the gene from each parent, which makes him more likely to develop Alzheimer’s than the rest.
Source: Variety
